UARK 2014-14: Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment

Clinical trial NCT02499081 · COMPLETED

Trial details

NCT number: NCT02499081
Sponsor: University of Arkansas
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2015-09-01
Primary completion: 2018-05-17
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.